Contact

For programmes where the evidence architecture can still be shaped, or dossiers with unresolved payer risk, thirty minutes is usually enough to clarify fit and where the work would have most leverage.

Schedule a Call

Thirty minutes. Confidential. No obligation. The call is with me.

Or send an enquiry

Name *

Email *

Company *

Therapeutic Area

Development Stage

Message *

Carl Haakon Samuelsen

Health Economist & Founder, Outcomes Analytica

Tønsberg, Norway · Global practice

carl@outcomes-analytica.no

LinkedIn Google Scholar

Most useful to include: the therapeutic area, the development stage, the markets in scope, and a one-sentence summary of the evidence question. That is enough for me to assess fit and likely scope.

Reply within one business day. Confidentiality and NDA standard.